Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraoperative Angiotensin 2 for the Prevention of Kidney Injury After Liver Transplant

NCT04592744 is registered in ClinicalTrials.gov with University of California, Los Angeles as lead sponsor.

NCT NCT04592744
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04592744 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraoperative Angiotensin 2 for the Prevention of Kidney Injury After Liver Transplant
Lead sponsor
University of California, Los Angeles
Phase
Phase 4
Overall status
Active, not recruiting
Start date
April 8, 2022
Completion date
December 31, 2026
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury, cirrhosis, liver, end stage liver disease, liver transplant; complications